Advertisement
Screener

Vincerx Pharma, Inc. Patents: Applications Pending

Vincerx Pharma, Inc. Patent Applications Pending

8 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-10-31: Application PCTUS2023036397; Invention COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCER; Applicant VINCERX PHARMA, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2023-04-13: Application 63459094; Invention COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCER; Applicant VINCERX PHARMA, INC.; Status Provisional Application Expired.
  • 2023-03-10: Application 63451324; Invention COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCER; Applicant VINCERX PHARMA, INC.; Status Provisional Application Expired.
  • 2022-12-09: Application 63431625; Invention COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR MULTIPLE MYELOMA; Applicant VINCERX PHARMA, INC.; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2023-10-31PCTUS2023036397COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCERVINCERX PHARMA, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SON TRAN
CHUNFEN ZHANG
RANJAN MAITY
NIZAR J. BAHLIS
PAOLA NERI
ARU NARENDRAN
AMY J. JOHNSON
MELANIE M. FRIGAULT
BEATRIX STELTE-LUDWIG
United States
United States
United States
United States
United States
United States
United States
United States
United States
2023-04-1363459094COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCERVINCERX PHARMA, INC.Provisional Application Expired
Son TRAN
Chunfen ZHANG
Ranjan MAITY
Nizar J. BAHLIS
Paola NERI
Aru NARENDRAN
Amy J. JOHNSON
Melanie M. FRIGAULT
Beatrix STELTE-LUDWIG
Canada
Canada
Canada
Canada
Canada
Canada
United States
United States
Germany
2023-03-1063451324COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCERVINCERX PHARMA, INC.Provisional Application Expired
Son TRAN
Chunfen ZHANG
Ranjan MAITY
Nizar J. BAHLIS
Paola NERI
Aru NARENDRAN
Amy J. JOHNSON
Melanie M. FRIGAULT
Beatrix STELTE-LUDWIG
Canada
Canada
Canada
Canada
Canada
Canada
United States
United States
Germany
2022-12-0963431625COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR MULTIPLE MYELOMAVINCERX PHARMA, INC.Provisional Application Expired
Son TRAN
Chunfen ZHANG
Ranjan MAITY
Nizar J. BAHLIS
Paola NERI
Aru NARENDRAN
Amy J. JOHNSON
Melanie M. FRIGAULT
Beatrix STELTE-LUDWIG
Canada
Canada
Canada
Canada
Canada
Canada
United States
United States
Germany
2022-11-0263421888COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR MULTIPLE MYELOMAVINCERX PHARMA, INC.Provisional Application Expired
Son TRAN
Chunfen ZHANG
Ranjan MAITY
Nizar J. BAHLIS
Paola NERI
Aru NARENDRAN
Amy J. JOHNSON
Melanie M. FRIGAULT
Beatrix STELTE-LUDWIG
Canada
Canada
Canada
Canada
Canada
Canada
United States
United States
Germany
2022-07-26PCTUS2022038281SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCERVINCERX PHARMA, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
SOOIN HWANG
BEATRIX STELTE-LUDWIG
United States
United States
2021-07-2663225819SELECTIVE CDK9 INHIBITOR FOR THE TREATMENT OF A RAS MUTANT CANCERVINCERX PHARMA, INC.Provisional Application Expired
Sooin HWANG
Beatrix STELTE-LUDWIG
United States
Germany
19153013COMBINATION THERAPIES COMPRISING A CDK9 INHIBITOR FOR CANCERVincerx Pharma Inc.Application Undergoing Preexam Processing
Son Tran
Chunfen Zhang
Ranjan Mairy
Nizar J. Bahlis
Paola Neri
Aru Nerandran
Amy J. Johnson
Melanie M. Frigault
Beatrix Stelte-Ludwig
Canada
Canada
United States
United States
United States
Canada
United States
United States
United States